| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |